Channing L Hinman

Title: Channing L. Hinman: Innovator in Medical Treatments

Introduction

Channing L. Hinman is a notable inventor based in Toledo, OH (US). He has made significant contributions to the field of medical treatments, particularly in the area of hyperplastic disorders and cancer therapies. With a total of 2 patents, his work showcases innovative approaches to complex health issues.

Latest Patents

Hinman's latest patents include groundbreaking methods for treating hyperplastic disorders. One of his notable inventions involves a method for treating a subject by injecting a therapeutic amount of a composition derived from a cobra toxin into the tissue of the subject. This method aims to diminish at least one symptom of a hyperplastic disorder. Additionally, he has developed cyclic beta-sheet peptides that are useful as apoptotic and cytotoxic cancer agents. These peptides and pharmaceutical compositions are particularly effective for treating cancers and include a synthetic peptide with a unique amino acid sequence differing from an initial loop of cobra cardiotoxin.

Career Highlights

Channing L. Hinman is affiliated with the University of Toledo, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical treatments and patient care.

Collaborations

Hinman has collaborated with esteemed colleagues, including Steven H. Selman and Charles A. Smith, contributing to a rich environment of innovation and research.

Conclusion

Channing L. Hinman's contributions to medical science through his patents and research at the University of Toledo highlight his role as a leading inventor in the field. His innovative approaches to treating hyperplastic disorders and cancer demonstrate the potential for significant advancements in healthcare.